139 related articles for article (PubMed ID: 22340102)
1. [Association between the serum TSH concentration and thyroid cancer incidence].
Li JZ; Jin YJ; Liu X; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
3. [Association between preoperative serum thyroid-stimulating hormone level and nonfunctioning malignant nodule thyroid disease].
Zeng Q; Liu J; Zhu J; Hu G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1931-3. PubMed ID: 25895308
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
[TBL] [Abstract][Full Text] [Related]
5. Serum thyrotropin concentration in children with isolated thyroid nodules.
Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
[TBL] [Abstract][Full Text] [Related]
6. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
7. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
Jin J; Machekano R; McHenry CR
Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
[TBL] [Abstract][Full Text] [Related]
8. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
9. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
Moon SS; Lee YS; Lee IK; Kim JG
Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
[TBL] [Abstract][Full Text] [Related]
10. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
11. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
[TBL] [Abstract][Full Text] [Related]
12. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
[TBL] [Abstract][Full Text] [Related]
13. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
14. Higher TSH level is a risk factor for differentiated thyroid cancer.
Kim HK; Yoon JH; Kim SJ; Cho JS; Kweon SS; Kang HC
Clin Endocrinol (Oxf); 2013 Mar; 78(3):472-7. PubMed ID: 22924613
[TBL] [Abstract][Full Text] [Related]
15. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
17. Correlation of TSH with the risk of paediatric thyroid carcinoma.
Chiu HK; Sanda S; Fechner PY; Pihoker C
Clin Endocrinol (Oxf); 2012 Aug; 77(2):316-22. PubMed ID: 22404106
[TBL] [Abstract][Full Text] [Related]
18. An elevated level of TSH might be predictive of differentiated thyroid cancer.
Dorange A; Triau S; Mucci-Hennekinne S; Bizon A; Laboureau-Soares S; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2011 Dec; 72(6):513-21. PubMed ID: 22115282
[TBL] [Abstract][Full Text] [Related]
19. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
20. The association between serum TSH concentration and thyroid cancer.
Boelaert K
Endocr Relat Cancer; 2009 Dec; 16(4):1065-72. PubMed ID: 19620248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]